Condition: HIV · Sponsor: City University of Hong Kong
HIV-serodiscordant male couples, in which one male partner is HIV-seropositive and the other is HIV-seronegative, experience multiple risks in HIV care and prevention. As stigma often hinders such couples' access to support and services, leveraging their relational resources is crucial for optimizing their outcomes. The proposed study will assess the efficacy of the three-session We-INtervention focusing on their relationship dynamics to enhance Chinese HIV-serodiscordant male couples' health and well-being. A total of 160 Chinese HIV-serodiscordant male couples (320 individuals: 160 HIV-seropositive and 160 HIV-seronegative) will be randomized at a 1:1 ratio to either the intervention or control arm. In the intervention arm, the We-INtervention will be delivered to both partners of each couple separately. In the control arm, each couple will receive health information pamphlets.
This description comes directly from the study's public registry record.
Nancy Xiaonan Yu, PhD · 34429436 · nancy.yu@cityu.edu.hk
Jianhua Hou, MS · 34429436 · jianhuhou2-c@my.cityu.edu.hk
Always discuss trial participation with your own doctor first.
| Fangzhouai Garden | Xiamen, Fujian, China | Recruiting |
| Guangzhou Yuele Healthcare Service Center | Guangzhou, Guangdong, China | Recruiting |
| Community Always There | Shenzhen, Guangdong, China | Recruiting |
| Jin Tang Six-Color Rainbow Healthcare Center | Chengdu, Sichuan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06639932